Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

56.03
Delayed Data
As of Dec 06
 +0.48 / +0.86%
Today’s Change
49.03
Today|||52-Week Range
77.12
-18.55%
Year-to-Date
Bristol-Myers Reports Data from Opdivo Combination Studies
Dec 06 / Zacks.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Dec 06 / MotleyFool.com - Paid Partner Content
3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come
Dec 01 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb Co. Stock Surged in November
Dec 03 / MotleyFool.com - Paid Partner Content
ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.
Nov 30 / Zacks.com - Paid Partner Content
Why Exelixis Was a Top Stock in 2016 So Far
Dec 02 / MotleyFool.com - Paid Partner Content
AVEO Partner Submits Response to Questions on Tivozanib
Nov 29 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Bristol-Myers, Google, Deere, Halliburton and Amer...
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close55.55
Today’s open55.71
Day’s range55.56 - 56.04
Volume5,924,415
Average volume (3 months)13,804,872
Market cap$92.8B
Dividend yield2.71%
Data as of 12/06/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+42.29%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+4.29%
P/E ratio28.0
Price/Sales6.97
Price/Book6.47

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.02+0.05%
CELGCelgene+0.83+0.71%
ABBVAbbVie+0.76+1.25%
SNYSanofi-0.25-0.61%
Data as of 8:12am ET, 12/07/2016

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.66
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts


Search for Jobs